reported that this ratio in newborn infants appeared to be within an acceptable range (more than 0.8) (4), indicating that the newborn infants may not be deficient in vitamin E. On the basis of our findings on red blood cell (RBC) tocopherol, which is also thought to be an expression of vitamin E status (9-11), the majority of newborn infants showed a normal vitamin E status (12, 13). However, there is no precise information in very low birth weight infants, based on such new indices for the assessment of vitamin E status. Plasma tocopherol levels probably may underestimate nutritional status of vitamin E in neonates. This report deals with vitamin E status in very low birth weight infants. In addition, changes in plasma and RBC tocopherol levels were examined after oral administration of vitamin E to neonates, because a theoretical and experimental basis is being developed which advocates the use of parenteral tocopherol in pharmacological doses as a form of therapy to ameliorate or totally treat a variety of neonatal disorders (13-21), al though some hazard and disappointing results have thus far been reported (22) (23) (24) (25) .
MATERIALS AND METHODS
Subjects. In the first study, forty newborn infants of very low birth weight were examined with respect to vitamin E status in our newborn nursery, from November 1984 to May 1985. Characteristics for the infants examined are documented in Table 1 . Eleven other infants born in the same period were excluded from this study, because six infants were severely ill and five infants died. The infants examined were divided into two groups based on the birth weight-less than 1,000g (group A), and 1,000-1,500g (group B).
In the second study, oral administration of a vitamin E preparation was undertaken after May 1985 in seven other premature infants. Their profiles are shown in Table 2 . None of the infants who were selected randomly had respiratory problems or feeding trouble during the examination periods.
The compositions of the human milk and formula used in this study are listed in Table 3 . All premature infants were first fed their own mother's milk by gastric gavage every 2h. Feedings were begun when the infant was stable (all within 1 week of birth) at a volume of 20-30ml/kg/day, increased by a similar amount daily so that all infants achieved 180ml/kg/day within 2 weeks, and maintained by daily adjustments according to weight increase. If the mother's milk was insufficient due to poor secretion, a formula (premature formula), listed in Table 3 , was added until the infants' body weight reached 1,500g. After 1,500g Was attained, a formula (regular formula) was used as an additional milk. An iron dosage of 6mg/day was administered after 2 weeks of life. None of the infants had parenteral nutrition which contained tocopherol. Gestational age was estimated by review of maternal records and confirmed by Dubowitz et al.'s examination (26) .
Administration of vitamin E. The daily oral administration was undertaken after 2 weeks of life. The vitamin E used was a very fine granule preparation of dl rac-alpha tocopheryl nicotinate (manufactured by Eisai Co., Ltd.) because of no increase in the osmolarity of the formula mixed preparation. The vitamin E preparation was suspended in a dosage of 10mg/kg into the formula, which was responding to 32 weeks of post-conceptional age), and thereafter there was a rise which coincided with that of the plasma level. On the other hand, in the group of shorter gestation the plasma and RBC tocopherol levels decreased and remained still at the lowest level at 11 weeks of life. 
Administration with vitamin E preparation
Changes in plasma and RBC tocopherol levels were examined in seven infants, as shown in Figs. 5 and 6. The three infants corresponding to group A showed no elevation of their plasma and RBC tocopherol levels during the first 4 or 5 weeks of the administration. However, this was followed by a prompt and marked elevation 
